Global Probiotics Tablets Market

Probiotics Tablets Comprehensive Study by Type (Digestive Support, Immune Support), Function (Regular, Preventive, Therapeutic), Ingredient (Bacteria, Yeast), End User (Child, Adult) Players and Region - Global Market Outlook to 2026

Probiotics Tablets Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Continuously increasing population of obese pollution and as well as majority of people has been suffering from gastrointestinal infections, digestive problems, vaginal infection, and others. Probiotics tablets are used for curing above diseases. Also, many established key players have been increasing the investment in research and development for manufacturing probiotic products which assists consumers in curing mentioned types of diseases. However, lack of awareness associated with the probiotics tablet is limiting the growth of the market.
This growth is primarily driven by Growing Consumption of Probiotic Tablets due to Health Benefits Associated with the Same and Increasing Awareness about Highly Efficient Probiotic Supplements.

Globally, a noticeable market trend is evident Technological Advancements and Increasing Participation of R&D Activities in Probiotic Tablet Development . The Biotechnology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as CVS/pharmacy (United States), Nature's Way Products, LLC (United States), Nature's Bounty Co. (United States), Airborne International B.V. (Netherlands), Indiana Botanic Gardens Inc.(United States), Aqua Flora (Canada), Renew Life Formulas, Inc. (United States), Jarrow Formulas, Inc. (United States), The Clorox Company (Rainbow Light) (United States) and Culturelle (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

On November 6, 2017, one of the most recognized and trusted consumers of dietary supplements brands "Nature’s Way Brands LLC" has introduced a new line of Single Herb Powders made with premium, dried herbs. The full line includes three herbal powders, selected for their unique health properties: Standardized Turmeric Powder to support joint health, and Beet (Beta vulgaris) root contains sugars and starches that make it a source of energy.* and Activated Coconut Charcoal Powder for internal cleansing*. These powders quickly dissolved in any beverage, making it easy to absorb the wellness benefits of turmeric, beetroot or activated coconut charcoal.

Regulatory Insights:
The Food Safety and Standards Act of 2005 (FSSA) defines the foods for special dietary uses or functional foods, nutraceuticals or health supplements. Currently, in India, probiotics are characterized as functional food rather than as pharmaceutical drugs and are regulated by food laws that regulate general food items. FSSA was passed by the Indian government with the purpose to regulate different varieties of eatables regulations covering nutraceuticals, foods and dietary supplements. According to FSSA, functional foods are defined legally but categorization of food categories, such as nutraceuticals, biotherapeutic agent is still unclear.

Market Drivers
  • Growing Consumption of Probiotic Tablets due to Health Benefits Associated with the Same
  • Increasing Awareness about Highly Efficient Probiotic Supplements

Market Trend
  • Technological Advancements and Increasing Participation of R&D Activities in Probiotic Tablet Development
  • Introduction to Probiotic Tablets which can Replace Pharmaceutical Agents

Restraints
  • Volatile Stringent International Regulations might Stagnate the International Trades
  • Higher Initial Investments in developing Probiotic Tablets with Negligible Manufacturing Tolerance

Opportunities
Increasing Health Consciousness across the Global Population and Increasing Demand for Probiotic Tablets from Developing Economies
Challenges
Skilled Workers are Required in Developing Probiotic Substrates

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Probiotics Tablets Study Sheds Light on
— The Probiotics Tablets Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Probiotics Tablets industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Probiotics Tablets industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Digestive Support
  • Immune Support
By Function
  • Regular
  • Preventive
  • Therapeutic

By Ingredient
  • Bacteria
  • Yeast

By End User
  • Child
  • Adult

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Consumption of Probiotic Tablets due to Health Benefits Associated with the Same
      • 3.2.2. Increasing Awareness about Highly Efficient Probiotic Supplements
    • 3.3. Market Challenges
      • 3.3.1. Skilled Workers are Required in Developing Probiotic Substrates
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements and Increasing Participation of R&D Activities in Probiotic Tablet Development
      • 3.4.2. Introduction to Probiotic Tablets which can Replace Pharmaceutical Agents
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Probiotics Tablets, by Type, Function, Ingredient, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Probiotics Tablets (Value)
      • 5.2.1. Global Probiotics Tablets by: Type (Value)
        • 5.2.1.1. Digestive Support
        • 5.2.1.2. Immune Support
      • 5.2.2. Global Probiotics Tablets by: Function (Value)
        • 5.2.2.1. Regular
        • 5.2.2.2. Preventive
        • 5.2.2.3. Therapeutic
      • 5.2.3. Global Probiotics Tablets by: Ingredient (Value)
        • 5.2.3.1. Bacteria
        • 5.2.3.2. Yeast
      • 5.2.4. Global Probiotics Tablets by: End User (Value)
        • 5.2.4.1. Child
        • 5.2.4.2. Adult
      • 5.2.5. Global Probiotics Tablets Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Probiotics Tablets (Volume)
      • 5.3.1. Global Probiotics Tablets by: Type (Volume)
        • 5.3.1.1. Digestive Support
        • 5.3.1.2. Immune Support
      • 5.3.2. Global Probiotics Tablets by: Function (Volume)
        • 5.3.2.1. Regular
        • 5.3.2.2. Preventive
        • 5.3.2.3. Therapeutic
      • 5.3.3. Global Probiotics Tablets by: Ingredient (Volume)
        • 5.3.3.1. Bacteria
        • 5.3.3.2. Yeast
      • 5.3.4. Global Probiotics Tablets by: End User (Volume)
        • 5.3.4.1. Child
        • 5.3.4.2. Adult
      • 5.3.5. Global Probiotics Tablets Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Probiotics Tablets (Price)
      • 5.4.1. Global Probiotics Tablets by: Type (Price)
  • 6. Probiotics Tablets: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. CVS/pharmacy (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Nature's Way Products, LLC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nature's Bounty Co. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Airborne International B.V. (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Indiana Botanic Gardens Inc.(United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Aqua Flora (Canada)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Renew Life Formulas, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Jarrow Formulas, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. The Clorox Company (Rainbow Light) (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Culturelle (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Probiotics Tablets Sale, by Type, Function, Ingredient, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Probiotics Tablets (Value)
      • 7.2.1. Global Probiotics Tablets by: Type (Value)
        • 7.2.1.1. Digestive Support
        • 7.2.1.2. Immune Support
      • 7.2.2. Global Probiotics Tablets by: Function (Value)
        • 7.2.2.1. Regular
        • 7.2.2.2. Preventive
        • 7.2.2.3. Therapeutic
      • 7.2.3. Global Probiotics Tablets by: Ingredient (Value)
        • 7.2.3.1. Bacteria
        • 7.2.3.2. Yeast
      • 7.2.4. Global Probiotics Tablets by: End User (Value)
        • 7.2.4.1. Child
        • 7.2.4.2. Adult
      • 7.2.5. Global Probiotics Tablets Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Probiotics Tablets (Volume)
      • 7.3.1. Global Probiotics Tablets by: Type (Volume)
        • 7.3.1.1. Digestive Support
        • 7.3.1.2. Immune Support
      • 7.3.2. Global Probiotics Tablets by: Function (Volume)
        • 7.3.2.1. Regular
        • 7.3.2.2. Preventive
        • 7.3.2.3. Therapeutic
      • 7.3.3. Global Probiotics Tablets by: Ingredient (Volume)
        • 7.3.3.1. Bacteria
        • 7.3.3.2. Yeast
      • 7.3.4. Global Probiotics Tablets by: End User (Volume)
        • 7.3.4.1. Child
        • 7.3.4.2. Adult
      • 7.3.5. Global Probiotics Tablets Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Probiotics Tablets (Price)
      • 7.4.1. Global Probiotics Tablets by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Probiotics Tablets: by Type(USD Million)
  • Figure 4. Global Probiotics Tablets: by Type USD Million (2015-2020)
  • Table 2. Probiotics Tablets Digestive Support , by Region USD Million (2015-2020)
  • Table 3. Probiotics Tablets Immune Support , by Region USD Million (2015-2020)
  • Table 4. Probiotics Tablets: by Function(USD Million)
  • Figure 5. Global Probiotics Tablets: by Function USD Million (2015-2020)
  • Table 5. Probiotics Tablets Regular , by Region USD Million (2015-2020)
  • Table 6. Probiotics Tablets Preventive , by Region USD Million (2015-2020)
  • Table 7. Probiotics Tablets Therapeutic , by Region USD Million (2015-2020)
  • Table 8. Probiotics Tablets: by Ingredient(USD Million)
  • Figure 6. Global Probiotics Tablets: by Ingredient USD Million (2015-2020)
  • Table 9. Probiotics Tablets Bacteria , by Region USD Million (2015-2020)
  • Table 10. Probiotics Tablets Yeast , by Region USD Million (2015-2020)
  • Table 11. Probiotics Tablets: by End User(USD Million)
  • Figure 7. Global Probiotics Tablets: by End User USD Million (2015-2020)
  • Table 12. Probiotics Tablets Child , by Region USD Million (2015-2020)
  • Table 13. Probiotics Tablets Adult , by Region USD Million (2015-2020)
  • Table 14. South America Probiotics Tablets, by Country USD Million (2015-2020)
  • Figure 8. South America Probiotics Tablets Share (%), by Country
  • Table 15. South America Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 16. South America Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 17. South America Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 18. South America Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 19. Brazil Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 20. Brazil Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 21. Brazil Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 22. Brazil Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 23. Argentina Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 24. Argentina Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 25. Argentina Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 26. Argentina Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 27. Rest of South America Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 29. Rest of South America Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 30. Rest of South America Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 31. Asia Pacific Probiotics Tablets, by Country USD Million (2015-2020)
  • Figure 9. Asia Pacific Probiotics Tablets Share (%), by Country
  • Table 32. Asia Pacific Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 33. Asia Pacific Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 34. Asia Pacific Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 35. Asia Pacific Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 36. China Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 37. China Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 38. China Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 39. China Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 40. Japan Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 41. Japan Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 42. Japan Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 43. Japan Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 44. India Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 45. India Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 46. India Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 47. India Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 48. South Korea Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 49. South Korea Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 50. South Korea Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 51. South Korea Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 52. Taiwan Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 53. Taiwan Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 54. Taiwan Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 55. Taiwan Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 56. Australia Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 57. Australia Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 58. Australia Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 59. Australia Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 64. Europe Probiotics Tablets, by Country USD Million (2015-2020)
  • Figure 10. Europe Probiotics Tablets Share (%), by Country
  • Table 65. Europe Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 66. Europe Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 67. Europe Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 68. Europe Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 69. Germany Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 70. Germany Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 71. Germany Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 72. Germany Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 73. France Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 74. France Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 75. France Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 76. France Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 77. Italy Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 78. Italy Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 79. Italy Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 80. Italy Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 81. United Kingdom Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 82. United Kingdom Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 83. United Kingdom Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 84. United Kingdom Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 85. Netherlands Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 86. Netherlands Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 87. Netherlands Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 88. Netherlands Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 89. Rest of Europe Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 90. Rest of Europe Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 91. Rest of Europe Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 92. Rest of Europe Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 93. MEA Probiotics Tablets, by Country USD Million (2015-2020)
  • Figure 11. MEA Probiotics Tablets Share (%), by Country
  • Table 94. MEA Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 95. MEA Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 96. MEA Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 97. MEA Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 98. Middle East Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 99. Middle East Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 100. Middle East Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 101. Middle East Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 102. Africa Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 103. Africa Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 104. Africa Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 105. Africa Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 106. North America Probiotics Tablets, by Country USD Million (2015-2020)
  • Figure 12. North America Probiotics Tablets Share (%), by Country
  • Table 107. North America Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 108. North America Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 109. North America Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 110. North America Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 111. United States Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 112. United States Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 113. United States Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 114. United States Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 115. Canada Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 116. Canada Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 117. Canada Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 118. Canada Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 119. Mexico Probiotics Tablets, by Type USD Million (2015-2020)
  • Table 120. Mexico Probiotics Tablets, by Function USD Million (2015-2020)
  • Table 121. Mexico Probiotics Tablets, by Ingredient USD Million (2015-2020)
  • Table 122. Mexico Probiotics Tablets, by End User USD Million (2015-2020)
  • Table 123. Probiotics Tablets Sales: by Type(K Units)
  • Figure 13. Global Probiotics Tablets: by Type K Units (2015-2020)
  • Table 124. Probiotics Tablets Sales Digestive Support , by Region K Units (2015-2020)
  • Table 125. Probiotics Tablets Sales Immune Support , by Region K Units (2015-2020)
  • Table 126. Probiotics Tablets Sales: by Function(K Units)
  • Figure 14. Global Probiotics Tablets: by Function K Units (2015-2020)
  • Table 127. Probiotics Tablets Sales Regular , by Region K Units (2015-2020)
  • Table 128. Probiotics Tablets Sales Preventive , by Region K Units (2015-2020)
  • Table 129. Probiotics Tablets Sales Therapeutic , by Region K Units (2015-2020)
  • Table 130. Probiotics Tablets Sales: by Ingredient(K Units)
  • Figure 15. Global Probiotics Tablets: by Ingredient K Units (2015-2020)
  • Table 131. Probiotics Tablets Sales Bacteria , by Region K Units (2015-2020)
  • Table 132. Probiotics Tablets Sales Yeast , by Region K Units (2015-2020)
  • Table 133. Probiotics Tablets Sales: by End User(K Units)
  • Figure 16. Global Probiotics Tablets: by End User K Units (2015-2020)
  • Table 134. Probiotics Tablets Sales Child , by Region K Units (2015-2020)
  • Table 135. Probiotics Tablets Sales Adult , by Region K Units (2015-2020)
  • Table 136. South America Probiotics Tablets Sales, by Country K Units (2015-2020)
  • Figure 17. South America Probiotics Tablets Share (%), by Country
  • Table 137. South America Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 138. South America Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 139. South America Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 140. South America Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 141. Brazil Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 142. Brazil Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 143. Brazil Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 144. Brazil Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 145. Argentina Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 146. Argentina Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 147. Argentina Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 148. Argentina Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 149. Rest of South America Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 150. Rest of South America Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 151. Rest of South America Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 152. Rest of South America Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 153. Asia Pacific Probiotics Tablets Sales, by Country K Units (2015-2020)
  • Figure 18. Asia Pacific Probiotics Tablets Share (%), by Country
  • Table 154. Asia Pacific Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 155. Asia Pacific Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 156. Asia Pacific Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 157. Asia Pacific Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 158. China Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 159. China Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 160. China Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 161. China Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 162. Japan Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 163. Japan Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 164. Japan Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 165. Japan Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 166. India Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 167. India Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 168. India Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 169. India Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 170. South Korea Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 171. South Korea Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 172. South Korea Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 173. South Korea Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 174. Taiwan Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 175. Taiwan Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 176. Taiwan Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 177. Taiwan Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 178. Australia Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 179. Australia Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 180. Australia Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 181. Australia Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 182. Rest of Asia-Pacific Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 183. Rest of Asia-Pacific Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 184. Rest of Asia-Pacific Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 185. Rest of Asia-Pacific Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 186. Europe Probiotics Tablets Sales, by Country K Units (2015-2020)
  • Figure 19. Europe Probiotics Tablets Share (%), by Country
  • Table 187. Europe Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 188. Europe Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 189. Europe Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 190. Europe Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 191. Germany Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 192. Germany Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 193. Germany Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 194. Germany Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 195. France Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 196. France Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 197. France Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 198. France Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 199. Italy Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 200. Italy Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 201. Italy Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 202. Italy Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 203. United Kingdom Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 204. United Kingdom Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 205. United Kingdom Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 206. United Kingdom Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 207. Netherlands Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 208. Netherlands Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 209. Netherlands Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 210. Netherlands Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 211. Rest of Europe Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 212. Rest of Europe Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 213. Rest of Europe Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 214. Rest of Europe Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 215. MEA Probiotics Tablets Sales, by Country K Units (2015-2020)
  • Figure 20. MEA Probiotics Tablets Share (%), by Country
  • Table 216. MEA Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 217. MEA Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 218. MEA Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 219. MEA Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 220. Middle East Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 221. Middle East Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 222. Middle East Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 223. Middle East Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 224. Africa Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 225. Africa Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 226. Africa Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 227. Africa Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 228. North America Probiotics Tablets Sales, by Country K Units (2015-2020)
  • Figure 21. North America Probiotics Tablets Share (%), by Country
  • Table 229. North America Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 230. North America Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 231. North America Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 232. North America Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 233. United States Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 234. United States Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 235. United States Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 236. United States Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 237. Canada Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 238. Canada Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 239. Canada Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 240. Canada Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 241. Mexico Probiotics Tablets Sales, by Type K Units (2015-2020)
  • Table 242. Mexico Probiotics Tablets Sales, by Function K Units (2015-2020)
  • Table 243. Mexico Probiotics Tablets Sales, by Ingredient K Units (2015-2020)
  • Table 244. Mexico Probiotics Tablets Sales, by End User K Units (2015-2020)
  • Table 245. Probiotics Tablets: by Type(USD/Units)
  • Figure 22. Global Probiotics Tablets: by Type USD/Units (2015-2020)
  • Figure 23. Global Probiotics Tablets share by Players 2020 (%)
  • Figure 24. Global Probiotics Tablets share by Players (Top 3) 2020(%)
  • Figure 25. Global Probiotics Tablets share by Players (Top 5) 2020(%)
  • Table 246. Company Basic Information, Sales Area and Its Competitors
  • Table 247. Company Basic Information, Sales Area and Its Competitors
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Probiotics Tablets: by Type(USD Million)
  • Figure 47. Global Probiotics Tablets: by Type USD Million (2021-2026)
  • Table 257. Probiotics Tablets Digestive Support , by Region USD Million (2021-2026)
  • Table 258. Probiotics Tablets Immune Support , by Region USD Million (2021-2026)
  • Table 259. Probiotics Tablets: by Function(USD Million)
  • Figure 48. Global Probiotics Tablets: by Function USD Million (2021-2026)
  • Table 260. Probiotics Tablets Regular , by Region USD Million (2021-2026)
  • Table 261. Probiotics Tablets Preventive , by Region USD Million (2021-2026)
  • Table 262. Probiotics Tablets Therapeutic , by Region USD Million (2021-2026)
  • Table 263. Probiotics Tablets: by Ingredient(USD Million)
  • Figure 49. Global Probiotics Tablets: by Ingredient USD Million (2021-2026)
  • Table 264. Probiotics Tablets Bacteria , by Region USD Million (2021-2026)
  • Table 265. Probiotics Tablets Yeast , by Region USD Million (2021-2026)
  • Table 266. Probiotics Tablets: by End User(USD Million)
  • Figure 50. Global Probiotics Tablets: by End User USD Million (2021-2026)
  • Table 267. Probiotics Tablets Child , by Region USD Million (2021-2026)
  • Table 268. Probiotics Tablets Adult , by Region USD Million (2021-2026)
  • Table 269. South America Probiotics Tablets, by Country USD Million (2021-2026)
  • Figure 51. South America Probiotics Tablets Share (%), by Country
  • Table 270. South America Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 271. South America Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 272. South America Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 273. South America Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 274. Brazil Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 275. Brazil Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 276. Brazil Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 277. Brazil Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 278. Argentina Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 279. Argentina Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 280. Argentina Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 281. Argentina Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 282. Rest of South America Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 283. Rest of South America Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 284. Rest of South America Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 285. Rest of South America Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 286. Asia Pacific Probiotics Tablets, by Country USD Million (2021-2026)
  • Figure 52. Asia Pacific Probiotics Tablets Share (%), by Country
  • Table 287. Asia Pacific Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 288. Asia Pacific Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 289. Asia Pacific Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 290. Asia Pacific Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 291. China Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 292. China Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 293. China Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 294. China Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 295. Japan Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 296. Japan Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 297. Japan Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 298. Japan Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 299. India Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 300. India Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 301. India Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 302. India Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 303. South Korea Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 304. South Korea Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 305. South Korea Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 306. South Korea Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 307. Taiwan Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 308. Taiwan Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 309. Taiwan Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 310. Taiwan Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 311. Australia Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 312. Australia Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 313. Australia Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 314. Australia Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 315. Rest of Asia-Pacific Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 316. Rest of Asia-Pacific Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 317. Rest of Asia-Pacific Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 318. Rest of Asia-Pacific Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 319. Europe Probiotics Tablets, by Country USD Million (2021-2026)
  • Figure 53. Europe Probiotics Tablets Share (%), by Country
  • Table 320. Europe Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 321. Europe Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 322. Europe Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 323. Europe Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 324. Germany Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 325. Germany Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 326. Germany Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 327. Germany Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 328. France Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 329. France Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 330. France Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 331. France Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 332. Italy Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 333. Italy Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 334. Italy Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 335. Italy Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 336. United Kingdom Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 337. United Kingdom Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 338. United Kingdom Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 339. United Kingdom Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 340. Netherlands Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 341. Netherlands Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 342. Netherlands Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 343. Netherlands Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 344. Rest of Europe Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 345. Rest of Europe Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 346. Rest of Europe Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 347. Rest of Europe Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 348. MEA Probiotics Tablets, by Country USD Million (2021-2026)
  • Figure 54. MEA Probiotics Tablets Share (%), by Country
  • Table 349. MEA Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 350. MEA Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 351. MEA Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 352. MEA Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 353. Middle East Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 354. Middle East Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 355. Middle East Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 356. Middle East Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 357. Africa Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 358. Africa Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 359. Africa Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 360. Africa Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 361. North America Probiotics Tablets, by Country USD Million (2021-2026)
  • Figure 55. North America Probiotics Tablets Share (%), by Country
  • Table 362. North America Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 363. North America Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 364. North America Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 365. North America Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 366. United States Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 367. United States Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 368. United States Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 369. United States Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 370. Canada Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 371. Canada Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 372. Canada Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 373. Canada Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 374. Mexico Probiotics Tablets, by Type USD Million (2021-2026)
  • Table 375. Mexico Probiotics Tablets, by Function USD Million (2021-2026)
  • Table 376. Mexico Probiotics Tablets, by Ingredient USD Million (2021-2026)
  • Table 377. Mexico Probiotics Tablets, by End User USD Million (2021-2026)
  • Table 378. Probiotics Tablets Sales: by Type(K Units)
  • Figure 56. Global Probiotics Tablets: by Type K Units (2021-2026)
  • Table 379. Probiotics Tablets Sales Digestive Support , by Region K Units (2021-2026)
  • Table 380. Probiotics Tablets Sales Immune Support , by Region K Units (2021-2026)
  • Table 381. Probiotics Tablets Sales: by Function(K Units)
  • Figure 57. Global Probiotics Tablets: by Function K Units (2021-2026)
  • Table 382. Probiotics Tablets Sales Regular , by Region K Units (2021-2026)
  • Table 383. Probiotics Tablets Sales Preventive , by Region K Units (2021-2026)
  • Table 384. Probiotics Tablets Sales Therapeutic , by Region K Units (2021-2026)
  • Table 385. Probiotics Tablets Sales: by Ingredient(K Units)
  • Figure 58. Global Probiotics Tablets: by Ingredient K Units (2021-2026)
  • Table 386. Probiotics Tablets Sales Bacteria , by Region K Units (2021-2026)
  • Table 387. Probiotics Tablets Sales Yeast , by Region K Units (2021-2026)
  • Table 388. Probiotics Tablets Sales: by End User(K Units)
  • Figure 59. Global Probiotics Tablets: by End User K Units (2021-2026)
  • Table 389. Probiotics Tablets Sales Child , by Region K Units (2021-2026)
  • Table 390. Probiotics Tablets Sales Adult , by Region K Units (2021-2026)
  • Table 391. South America Probiotics Tablets Sales, by Country K Units (2021-2026)
  • Figure 60. South America Probiotics Tablets Share (%), by Country
  • Table 392. South America Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 393. South America Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 394. South America Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 395. South America Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 396. Brazil Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 397. Brazil Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 398. Brazil Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 399. Brazil Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 400. Argentina Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 401. Argentina Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 402. Argentina Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 403. Argentina Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 404. Rest of South America Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 405. Rest of South America Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 406. Rest of South America Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 407. Rest of South America Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 408. Asia Pacific Probiotics Tablets Sales, by Country K Units (2021-2026)
  • Figure 61. Asia Pacific Probiotics Tablets Share (%), by Country
  • Table 409. Asia Pacific Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 410. Asia Pacific Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 411. Asia Pacific Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 412. Asia Pacific Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 413. China Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 414. China Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 415. China Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 416. China Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 417. Japan Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 418. Japan Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 419. Japan Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 420. Japan Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 421. India Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 422. India Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 423. India Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 424. India Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 425. South Korea Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 426. South Korea Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 427. South Korea Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 428. South Korea Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 429. Taiwan Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 430. Taiwan Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 431. Taiwan Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 432. Taiwan Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 433. Australia Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 434. Australia Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 435. Australia Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 436. Australia Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 437. Rest of Asia-Pacific Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 438. Rest of Asia-Pacific Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 439. Rest of Asia-Pacific Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 440. Rest of Asia-Pacific Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 441. Europe Probiotics Tablets Sales, by Country K Units (2021-2026)
  • Figure 62. Europe Probiotics Tablets Share (%), by Country
  • Table 442. Europe Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 443. Europe Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 444. Europe Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 445. Europe Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 446. Germany Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 447. Germany Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 448. Germany Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 449. Germany Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 450. France Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 451. France Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 452. France Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 453. France Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 454. Italy Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 455. Italy Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 456. Italy Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 457. Italy Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 458. United Kingdom Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 459. United Kingdom Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 460. United Kingdom Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 461. United Kingdom Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 462. Netherlands Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 463. Netherlands Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 464. Netherlands Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 465. Netherlands Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 466. Rest of Europe Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 467. Rest of Europe Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 468. Rest of Europe Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 469. Rest of Europe Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 470. MEA Probiotics Tablets Sales, by Country K Units (2021-2026)
  • Figure 63. MEA Probiotics Tablets Share (%), by Country
  • Table 471. MEA Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 472. MEA Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 473. MEA Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 474. MEA Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 475. Middle East Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 476. Middle East Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 477. Middle East Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 478. Middle East Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 479. Africa Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 480. Africa Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 481. Africa Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 482. Africa Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 483. North America Probiotics Tablets Sales, by Country K Units (2021-2026)
  • Figure 64. North America Probiotics Tablets Share (%), by Country
  • Table 484. North America Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 485. North America Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 486. North America Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 487. North America Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 488. United States Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 489. United States Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 490. United States Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 491. United States Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 492. Canada Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 493. Canada Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 494. Canada Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 495. Canada Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 496. Mexico Probiotics Tablets Sales, by Type K Units (2021-2026)
  • Table 497. Mexico Probiotics Tablets Sales, by Function K Units (2021-2026)
  • Table 498. Mexico Probiotics Tablets Sales, by Ingredient K Units (2021-2026)
  • Table 499. Mexico Probiotics Tablets Sales, by End User K Units (2021-2026)
  • Table 500. Probiotics Tablets: by Type(USD/Units)
  • Figure 65. Global Probiotics Tablets: by Type USD/Units (2021-2026)
  • Table 501. Research Programs/Design for This Report
  • Table 502. Key Data Information from Secondary Sources
  • Table 503. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. CVS/pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 28. CVS/pharmacy (United States) Revenue: by Geography 2020
  • Figure 29. Nature's Way Products, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 30. Nature's Way Products, LLC (United States) Revenue: by Geography 2020
  • Figure 31. Nature's Bounty Co. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Nature's Bounty Co. (United States) Revenue: by Geography 2020
  • Figure 33. Airborne International B.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 34. Airborne International B.V. (Netherlands) Revenue: by Geography 2020
  • Figure 35. Indiana Botanic Gardens Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 36. Indiana Botanic Gardens Inc.(United States) Revenue: by Geography 2020
  • Figure 37. Aqua Flora (Canada) Revenue, Net Income and Gross profit
  • Figure 38. Aqua Flora (Canada) Revenue: by Geography 2020
  • Figure 39. Renew Life Formulas, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Renew Life Formulas, Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Jarrow Formulas, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Jarrow Formulas, Inc. (United States) Revenue: by Geography 2020
  • Figure 43. The Clorox Company (Rainbow Light) (United States) Revenue, Net Income and Gross profit
  • Figure 44. The Clorox Company (Rainbow Light) (United States) Revenue: by Geography 2020
  • Figure 45. Culturelle (United States) Revenue, Net Income and Gross profit
  • Figure 46. Culturelle (United States) Revenue: by Geography 2020
List of companies from research coverage that are profiled in the study
  • CVS/pharmacy (United States)
  • Nature's Way Products, LLC (United States)
  • Nature's Bounty Co. (United States)
  • Airborne International B.V. (Netherlands)
  • Indiana Botanic Gardens Inc.(United States)
  • Aqua Flora (Canada)
  • Renew Life Formulas, Inc. (United States)
  • Jarrow Formulas, Inc. (United States)
  • The Clorox Company (Rainbow Light) (United States)
  • Culturelle (United States)
Additional players considered in the study are as follows:
Olly Public Benefit Corporation (United States) , Aurobindo Pharma USA, Inc. (Natrol) (United States) , American Health, Inc. (United States) , iHerb Holdings, LLC (United States) , Irwin Naturals (United States)
Select User Access Type

Key Highlights of Report


Jan 2022 201 Pages 63 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Probiotics Tablets Market Quantitative research analysis
Global Probiotics Tablets Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Probiotics Tablets market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Probiotics Tablets market are CVS/pharmacy (United States), Nature's Way Products, LLC (United States), Nature's Bounty Co. (United States), Airborne International B.V. (Netherlands), Indiana Botanic Gardens Inc.(United States), Aqua Flora (Canada), Renew Life Formulas, Inc. (United States), Jarrow Formulas, Inc. (United States), The Clorox Company (Rainbow Light) (United States) and Culturelle (United States), to name a few.
North America is dominating the Probiotics Tablets Market.

Know More About Global Probiotics Tablets Market Report?

Have a Query? Click Here

Other Related Reports

NGS Sample Preparation Comprehensive Study by Application (Whole Genome Sequence (WGS), Exome Sequencing, RNA Sequencing, Methylation Sequencing), Workflow  (Library Preparation, Cluster Generation, ...
$ 3750
Gram Staining System Comprehensive Study by Type (Gram Staining System Regents, Automated Gram Staining System, Accessories), Application (Contract Research Organizations, Diagnostic Laboratories, Ho...
$ 3350
Genome Engineering Comprehensive Study by Type (Reagents & Consumables, Software & Systems, Services), Application (Cell Line Engineering , Animal Genetic Engineering , Plant Genetic Engineering , Ot...
$ 3750
Cell Viability Assays Comprehensive Study by Type (Human Cells, Microbial Cells, Animal Cells), Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Ap...
$ 3650
Nutrigenomics Comprehensive Study by Type (Reagents & kits, Services), Application (Obesity, Diabetes, Anti-Aging, Chronic Diseases), Techniques (Saliva, Buccal Swab, Blood, Others) Players and Regio...
$ 3500
Genetically Modified Food Comprehensive Study by Type (Herbicide Tolerance (HR), Insect Resistance (IR), Stacked Traits (ST)), Application (Crops, Vegetables, Fruits, Animal Products), Crop (Corn, Co...
$ 3350